Bepreve was finally approved for release on the US Market by the FDA. This decision will certainly help ISTA break even on its operating income in 2009 and ISTA could possibly make a net profit in 2010.
In January 2009 FDA announced it would review NDA for Bepreve with an action date of September 12, 2009. Bepreve would be ISTA's 4th marketed products with high growth potential